Vertex Pharmaceuticals Inc
VRTX
$519.51
+0.79%
Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc is a Biotechnology company listed on NASDAQ NMS - GLOBAL MARKET.
Industry
Biotechnology
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$121.1B
P/E Ratio
30.1
Cash on Hand
$6.6B(positive)
Shares Outstanding
253.8M shares
Currency
USD
Earnings (EPS)
QuarterEPS EstimateEPS Actual
Q2 2026$4.83$4.73
Q1 2026$4.40$4.47
Q4 2025$5.17$5.03
Q3 2025$4.65$4.80
Financial Highlights
The basics, explained simply — no finance degree required.
52-Week Range
$374.17 – $560.25
The lowest and highest price this stock has traded at over the past year.
Profit Margin
35.0%
How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.
Revenue Growth
+10.2%
How much the company's sales grew compared to a year ago.
Volatility (Beta)
0.28
How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.
Analyst Insights
Insider Activity
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.
SACHS BRUCE I
Aug 27, 2026
Sold 6,000
Sachdev Amit
Jul 21, 2026
Bought 8,251
Tatsis Ourania
Jul 21, 2026
Bought 8,251
SACHS BRUCE I
Jul 15, 2026 • $475.28/share
Bought 100
Garber Alan M
Jul 15, 2026 • $475.28/share
Bought 32
Tatsis Ourania
Jul 2, 2026 • $524.99/share
Sold 1,500